PASW Stock Forecast: Ping An Biomedical Co., Ltd. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 2 of 100 as at 17 Sept 2026 — in the weakest quartile.
PASW stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Ping An Biomedical Co., Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (89): Smaller than most of the companies we track.
Issuance (0): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
PASW stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on PASW, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. PASW appears on the weeks it earns a place.
PASW vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, Ping An Biomedical Co., Ltd. returned −89.7% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
PASW analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Ping An Biomedical Co., Ltd. (PASW) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.7×
- Price / book
- 1.5×
- EV / EBITDA
- −0.6×
Cheaper than 77% of US stocks
Cheaper than 86% of US stocks
Cheaper than 65% of US stocks
- Revenue growth (YoY)
- −47.4%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- 5.6%
- Net margin
- −14.8%
Higher than 6% of US stocks
Higher than 56% of US stocks
Higher than 17% of US stocks
- Return on equity
- −11.4%
- Return on assets
- −8.9%
- Dividend yield
- —
Higher than 35% of US stocks
Higher than 27% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Ping An Biomedical Co., Ltd. (PASW) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Ping An Biomedical Co., Ltd. has a market value of $17.3M and an enterprise value of $976K.
Ping An Biomedical Co., Ltd. employs 7 people.
Data provided by Twelve Data
PASW vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| PASWPing An Biomedical Co., Ltd. | $17.3M | 2 |
| SMJFSMJ International Holdings, Inc. | $29.1M | 1 |
| CULPCulp, Inc. | $46.1M | 77 |
| UFIUnifi, Inc. | $122.3M | 70 |
| ARKRArk Restaurants Corp.* | $16.8M | 42 |
| EFOIEnergy Focus, Inc.* | $16.5M | 27 |
| MGIHMillennium Group International Holdings Ltd.* | $17.6M | 33 |
* Nearest Consumer Cyclical names by size — few textile manufacturing companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Ping An Biomedical Co., Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about PASW stock
How does Ticker Nerd's model rank PASW?
As at 17 Sept 2026, Ping An Biomedical Co., Ltd. ranks 2 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (89 of 100).
What is the PASW stock forecast for 2030?
No analyst covering Ping An Biomedical Co., Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PASW are extrapolating price history, which says nothing about the business.
How has PASW stock performed over the past year?
Ping An Biomedical Co., Ltd. returned -89.7% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Ping An Biomedical Co., Ltd. do?
Ping An Biomedical Co., Ltd. is a Hong Kong-based company that provides supply chain management services for the apparel industry.
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd. is a Hong Kong-based company that provides supply chain management services for the apparel industry. Its operations cover market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company also manufactures and trades yarns, textiles, and finished garments, while offering warehousing services and real estate property investment. It serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion retailers across markets in China, Hong Kong, Cambodia, and Europe. Ping An Biomedical Co., Ltd. focuses on integrated, one-stop solutions that connect sourcing, production, and delivery across the textile value chain. Its business mix also includes healthcare and biomedical technology initiatives, adding a broader industrial and service-oriented profile to its current operations.
CEO Mr. Pijun Liu · 7 employees · Hong Kong · https://newbrandcashmere.com